
Pregnancy inflammation study points to a window for protecting hearts
A small UK study has identified a possible link between inflammation during pregnancies affected by high blood pressure and heart changes that persist after birth. Researchers followed 60 women, including 38 with pre-eclampsia or gestational hypertension, through pregnancy and up to six months afterwards.
Inflammatory signals measured before birth were associated with poorer heart structure and function later, even after blood inflammation had settled. The team then used a mouse model to explore cause: progesterone given during pregnancy reduced inflammation and prevented later cardiac dysfunction, while treatment after birth did not.

Gilbert considers how pregnancy inflammation might affect the heart after birth. Conceptual AI image: Good News Gilbert, generated from the approved AI Gilbert identity reference; not a depiction of the study.
This does not show that progesterone is a safe or effective treatment for pregnant women. The human group was small and observational, and the intervention was tested only in mice. Queen Mary University of London and the British Heart Foundation say larger, longer studies are needed.
The useful advance is a clearer mechanism and timing to test. If future clinical research confirms it, existing anti-inflammatory medicines might be assessed during pregnancy, when the heart changes may still be preventable — a focused route towards protecting women’s long-term heart health.
Sources
React to this story
Keep the useful discoveries coming.
Get stories around your interests, with links to the evidence and context, in a free email on some Fridays.
See an example and sign up

